Please assess the completion status of the following clinical trial:

Trial Title: Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signature of the consent form~* Patients with hepatic lesion needing a major hepatectomy (≥ 3 hepatic segments)~Exclusion Criteria:~* Absence of signature of the consent form~* Patient with cirrhosis~* Minor hepatectomy (\< 3 hepatic segments)~* Hepatectomy associated with vascular resection~* Contraindication of tranexamic acid : history of arterial or venous thrombosis , disseminated intravascular coagulation, severe renal insufficiency, history of epilepsies , intrathecal or intraventricular injection~* Pregnant or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- acid tranexamic (Type: EXPERIMENTAL): acid tranexamic
- 2 (Type: PLACEBO_COMPARATOR): Nacl 0.9%

Based on this trial design, predict the completion outcome and termination type (if applicable).